PROCEPT BioRobotics FY23 Revenue Outlook $128M Vs. $126.11M Estimate

Full Year 2023 Financial Guidance The Company projects revenue for the full year 2023 to be $128 million, which represents 71% growth over the Company's prior year revenue. This compares to previous revenue

Full Year 2023 Financial Guidance

  • The Company projects revenue for the full year 2023 to be $128 million, which represents 71% growth over the Company’s prior year revenue. This compares to previous revenue guidance of $125 million.
  • The Company projects full year 2023 gross margin to be approximately 54%. This compares to previous guidance of approximately 53%.
  • The Company projects full year 2023 total operating expense of approximately $167 million. This compares to previous guidance of approximately $163 million.
  • The Company reiterates full year 2023 Adjusted EBITDA loss to be ($70.5) million.

Adjusted EBITDA is a financial measure that is not prepared in accordance with generally accepted accounting principles in the United States (GAAP). For more information about the Company’s use of non-GAAP financial measures, please see the section below titled “Use of Non-GAAP Financial Measures (Unaudited).”

Total
0
Shares
Related Posts